New Proposal of type 3 neovascularization
Read original article here : https://www.ncbi.nlm.nih.gov/pubmed/30550528
Brolucizumab
Brolucizumab (also known as RTH258) is a humanized single-chain antibody fragment that inhibits all isoforms of VEGF-A with a molecular weight of 26 kDa. “On a molar basis, 6 mg…
Polypoidal Choroidal Vasculopathy Landmark Studies
Medical Treatment of PCV Current treatment plans can be formulated based on three pieces of information: the location of the PCV complex, the baseline vision, and the response to previous…
Posted injournal club
Protocol V Sheds Light on Managing Mild Diabetic Macular Edema
Medscape Ophthalmology Headlines / 2019-07-30 When it comes to the treatment of diabetic macular edema (DME), ophthalmologists have overwhelming evidence to guide their decision-making—but only up to a point. DME…